AGP Executive Report
Last update: an hour agoMaternal Health: Australia’s maternal RSV vaccination program is showing strong real-world results, with a new study in JAMA Pediatrics finding vaccination during pregnancy highly effective at preventing RSV hospitalisation in infants aged 6 months and under, especially in the first two months of life. Cancer Care: Moderna and Merck report a major Phase 3 milestone for a personalised neoantigen mRNA cancer vaccine in high-risk melanoma, with the combo plus Keytruda significantly reducing the risk of recurrence or spread versus Keytruda alone. Cardiac Surgery Breakthrough: An Australian-led trial reports that giving intravenous iron to anaemic patients before elective heart surgery reduces the need for blood transfusions and improves recovery outcomes, including fewer blood products used per 100 patients. Health & Policy Watch: Australia is set to implement an “opt-out” gambling advertising register, funded by a levy on sportsbooks, as regulators move to curb exposure. Community & Wellbeing: A new dementia-focused push in Tasmania aims to boost education and inclusive communities, while local groups continue to drive suicide prevention and mental health support initiatives.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.